PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, United States of America.\', \'Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, United States of America.\', \'Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America.\', \'Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America.\', \'Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.\', \'Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, Texas, United States of America.\', \'Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.ppat.1009599
?:doi
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 34043740
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
is ?:relation_isRelatedTo_publication of
?:title
  • TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all